Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Glycyrrhiza glabra var. persica
Persian licorice variety central to Unani medicine used for respiratory, digestive, and hormonal conditions.
Unani Mulethi Root (Glycyrrhiza glabra var. persica) is a Persian licorice variety central to Unani medicine, valued for its expectorant, anti-inflammatory, and adrenal-supporting properties. Its primary active compounds—glycyrrhizin, glabridin, liquiritin, and isoliquiritin—underlie its therapeutic effects on respiratory, digestive, and hormonal conditions. Evidence is limited to preliminary studies and traditional use, with safety concerns including hypertension and potassium loss with prolonged use.
Glycyrrhizin inhibits 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), potentiating cortisol's mineralocorticoid and anti-inflammatory actions. Glabridin suppresses NF-κB and COX-2 pathways, reducing oxidative stress and inflammation. Liquiritin and isoliquiritin modulate serotonin and dopamine receptors, contributing to mood and digestive regulation. Additionally, glycyrrhizin exhibits antiviral activity by inhibiting viral replication and enhancing interferon production, while the root's demulcent properties soothe irritated mucous membranes.
Persian licorice variety central to Unani medicine used for respiratory, digestive, and hormonal conditions.
Unani Mulethi Root (Glycyrrhiza glabra var. persica) is a Persian licorice variety central to Unani medicine, valued for its expectorant, anti-inflammatory, and adrenal-supporting properties. Its primary active compounds—glycyrrhizin, glabridin, liquiritin, and isoliquiritin—underlie its therapeutic effects on respiratory, digestive, and hormonal conditions. Evidence is limited to preliminary studies and traditional use, with safety concerns including hypertension and potassium loss with prolonged use.
Glycyrrhizin inhibits 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), potentiating cortisol's mineralocorticoid and anti-inflammatory actions. Glabridin suppresses NF-κB and COX-2 pathways, reducing oxidative stress and inflammation. Liquiritin and isoliquiritin modulate serotonin and dopamine receptors, contributing to mood and digestive regulation. Additionally, glycyrrhizin exhibits antiviral activity by inhibiting viral replication and enhancing interferon production, while the root's demulcent properties soothe irritated mucous membranes.